We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04668339
Recruitment Status : Terminated (A decision was made to terminate the study for operational/business reasons. The study was not terminated for reasons of safety or immunogenicity.)
First Posted : December 16, 2020
Last Update Posted : July 8, 2022
Information provided by (Responsible Party):
Arcturus Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 1, 2022
Actual Study Completion Date : March 1, 2022